1. Home
  2. NKTX vs BAFN Comparison

NKTX vs BAFN Comparison

Compare NKTX & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$2.25

Market Cap

198.2M

Sector

Health Care

ML Signal

N/A

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$5.47

Market Cap

175.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NKTX
BAFN
Founded
2015
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
175.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
NKTX
BAFN
Price
$2.25
$5.47
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $10.83
N/A
AVG Volume (30 Days)
★ 560.9K
127.7K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 11.88
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$4.26
52 Week High
$3.72
$10.38

Technical Indicators

Market Signals
Indicator
NKTX
BAFN
Relative Strength Index (RSI) 31.83 32.64
Support Level $1.96 $4.53
Resistance Level $2.50 $6.75
Average True Range (ATR) 0.16 0.78
MACD -0.07 -0.24
Stochastic Oscillator 12.35 0.00

Price Performance

Historical Comparison
NKTX
BAFN

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company that operates through its wholly owned subsidiary. The Company generates the majority of its revenue from interest on loans and noninterest income. The primary sources of funding for its loans are loan payments, deposits, and borrowings. It is dependent on noninterest income, which is derived from net gain on the sales of the guaranteed portion of government-guaranteed loans and service fee income. The company provides personal banking and business banking services.

Share on Social Networks: